Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3

被引:100
作者
Fuchs, Alexander [1 ]
Leigh, Mathew [2 ]
Kloefer, Bastian [3 ]
Dressman, Jennifer B. [1 ]
机构
[1] Goethe Univ Frankfurt, Inst Pharmaceut Technol, D-60438 Frankfurt, Germany
[2] Biorelevant Com, Croydon, England
[3] Legacy Pharmaceut Switzerland GmbH, Basel, Switzerland
关键词
FaSSIF; Fasted state; Human intestinal fluid; Surface tension; Biorelevant media; Solubility; Bile salts; Lysolecithin; ORAL-DRUG ABSORPTION; IN-VITRO; GASTROINTESTINAL-TRACT; PHYSICOCHEMICAL PROPERTIES; BIORELEVANT MEDIA; DISSOLUTION MEDIA; SOLUBLE DRUGS; WEAK BASES; SOLUBILITY; DELIVERY;
D O I
10.1016/j.ejpb.2015.05.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Biorelevant media are commonly used to simulate the physiological composition of human intestinal fluids (HIF) in in vitro solubility and dissolution investigations. In comparison with the surfactant solutions or blank buffers, these media are able to better reflect the physiological solubility and dissolution behavior of poorly soluble active pharmaceutical ingredients (APIs). The aim of this investigation was to review the composition of FaSSIF and FaSSIF-V2 according to recently summarized data about the physiological composition of fasted state human intestinal fluid and propose an updated version, FaSSIF-V3. Furthermore the surface tension was considered as a possible surrogate parameter to gauge the physiological correctness of new versions of biorelevant media. Various prototypes of FaSSIF-V3 were prepared with each of the following five bile salts: taurocholate (TC), glycocholate (GC), tauroursodeoxycholate (TUDC), taurochenodeoxycholate (TCDC) and glycochenodeoxycholate (GCDC) as well as replacing lecithin with its hydrolysis products, lysolecithin and sodium oleate. Two additional media consisting of a mixture of glycocholate (GC) and taurocholate (TG), with or without 0.2 mM cholesterol, were also investigated. Solubilities of ten model compounds in various prototypes of FaSSIF-V3 were measured using HPLC-UV and compared to the solubilities in the existing biorelevant media (FaSSIF and FaSSIF-V2), fasted HIF, blank buffer and a 0.5% sodium dodecyl sulfate (SDS) solution. Additionally, the influence on the surface tension properties of various combinations of bile salts, phospholipids and their hydrolysis products and cholesterol in these media was investigated and an attempt was made to calculate the CMC of the various generations of FaSSIF. The results demonstrated that the amount and the type of phospholipids as well as the type of bile salt had a significant influence on the solubility and surface tension in the various FaSSIF-V3 prototypes and existing biorelevant media. In contrast to results with biorelevant media, it was demonstrated that blank buffers generally underestimate and SDS solutions highly overestimate the physiological relevant solubilities of all investigated APIs. The prototype containing FaSSIF-V3-GC/TC_Chol was able to better reflect the solubilities of the most investigated APIs in fasted HIF than the existing media, and it also matched the physiological surface tension reported for the fasted human gut, and was designated FaSSIF-V3. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:229 / 240
页数:12
相关论文
共 53 条
  • [1] Ex vivo permeability experiments in excised rat intestinal tissue and in vitro solubility measurements in aspirated human intestinal fluids support age-dependent oral drug absorption
    Annaert, Pieter
    Brouwers, Joachim
    Bijnens, Ann
    Lammert, Frank
    Tack, Jan
    Augustijns, Patrick
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 39 (1-3) : 15 - 22
  • [2] [Anonymous], EUR J PHARM SCI
  • [3] Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state
    Arndt, Marcel
    Chokshi, Hitesh
    Tang, Kin
    Parrott, Neil J.
    Reppas, Christos
    Dressman, Jennifer B.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 84 (03) : 633 - 641
  • [4] INTESTINAL DIGESTION AND ABSORPTION OF CHOLESTEROL AND LECITHIN IN HUMAN - INTUBATION STUDIES WITH A FAT-SOLUBLE REFERENCE SUBSTANCE
    ARNESJO, B
    NILSSON, A
    BARROWMAN, J
    BORGSTROM, B
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1969, 4 (08) : 653 - +
  • [5] A review of drug solubility in human intestinal fluids: Implications for the prediction of oral absorption
    Augustijns, Patrick
    Wuyts, Benjamin
    Hens, Bart
    Annaert, Pieter
    Butler, James
    Brouwers, Joachim
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 57 : 322 - 332
  • [6] Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs
    Bergstrom, Christel A. S.
    Holm, Rene
    Jorgensen, Soren Astrup
    Andersson, Sara B. E.
    Artursson, Per
    Beato, Stefania
    Borde, Anders
    Box, Karl
    Brewster, Marcus
    Dressman, Jennifer
    Feng, Kung-I.
    Halbert, Gavin
    Kostewicz, Edmund
    McAllister, Mark
    Muenster, Uwe
    Thinnes, Julian
    Taylor, Robert
    Mullertz, Anette
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 57 : 173 - 199
  • [7] Excipient-Mediated Supersaturation Stabilization in Human Intestinal Fluids
    Bevernage, Jan
    Forier, Thomas
    Brouwers, Joachim
    Tack, Jan
    Annaert, Pieter
    Augustijns, Patrick
    [J]. MOLECULAR PHARMACEUTICS, 2011, 8 (02) : 564 - 570
  • [8] Drug Supersaturation in Simulated and Human Intestinal Fluids Representing Different Nutritional States
    Bevernage, Jan
    Brouwers, Joachim
    Clarysse, Sarah
    Vertzoni, Maria
    Tack, Jan
    Annaert, Pieter
    Augustijns, Patrick
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (11) : 4525 - 4534
  • [9] Is bicarbonate buffer suitable as a dissolution medium?
    Boni, Julia Elisabeth
    Brickl, Rolf Stefan
    Dressman, Jennifer
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 (10) : 1375 - 1382
  • [10] Intraluminal drug and formulation behavior and integration in in vitro permeability estimation:: A case study with amprenavir
    Brouwers, J
    Tack, J
    Lammert, F
    Augustijns, P
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (02) : 372 - 383